Fluticasone + Salmeterol (Fluticasone + Salmeterol )

Fluticasone + Salmeterol Inhalers: Patient-Friendly Guide for Australia

Basic Product Information

Mechanism of Action

• For Everyone: Fluticasone is a corticosteroid. It helps to reduce inflammation (swelling and irritation) in your airways, making it easier to breathe. Salmeterol is a long-acting bronchodilator. It helps keep your airways open by relaxing the muscles around them. The combination helps control asthma and COPD symptoms.
• For Healthcare Professionals: Fluticasone propionate exerts potent anti-inflammatory effects in the bronchial mucosa via glucocorticoid receptor agonism, suppressing multiple inflammatory cytokines. Salmeterol xinafoate is a selective β2-adrenoceptor agonist, producing long-acting bronchodilation through cAMP pathway stimulation. Their combined, synergistic action improves disease control while reducing exacerbations.

Pharmacokinetics

• Absorption: Inhaled drugs are predominantly deposited in the lungs, with minimal gastrointestinal absorption. Fluticasone undergoes extensive first-pass metabolism.
• Metabolism: Fluticasone is metabolised in the liver (CYP3A4) to inactive metabolites. Salmeterol is also metabolised in the liver through hydroxylation.
• Elimination: Excretion is mainly via faeces (fluticasone, salmeterol) and urine to a lesser extent.
• Time to Onset/Duration: Salmeterol starts working in about 10-20 minutes (lasting up to 12 hours), while fluticasone helps build an anti-inflammatory effect over days to weeks.

Everyday Use & Best Practices (Australia Context)

• Typical Adult Dose: One inhalation twice daily (morning and evening) as prescribed; doses depend on severity (see dosing table below).
• Children: Dosage and device may be adjusted for children by the doctor. Always follow the prescribed strength.
• Use the inhaler every day, even if you’re feeling well. It is for maintenance use, not for sudden asthma attacks (seek separate reliever inhaler such as salbutamol for that).
• Always rinse your mouth with water afterwards to reduce the risk of mouth thrush.
• Keep your inhaler clean and ensure you have repeat prescriptions arranged with your GP or pharmacist.
• Check Australian seasonal advice (e.g., bushfire season, pollen, respiratory viruses) with your healthcare team if concerned.

Best Time to Take: Morning vs Evening

• Morning and evening dosed 12 hours apart is standard for optimal control.
• Consistency is important—use at the same times each day to keep medication levels steady and protect against night-time symptoms.
• If you miss a dose, take it as soon as you remember unless it's time for the next dose. Do not double the dose.
• Some people find taking it after breakfast and dinner fits best with their routine.

Taking with Food or on an Empty Stomach

• The medicine is inhaled—food has minimal effect on its action.
• It can be used before or after eating. In Australia, there are no specific dietary restrictions for this medicine.
• Just rinse your mouth well after each inhalation, regardless of meal times.

Interaction Warnings

Indications

Dosing According to Clinical Indication & Age

Safety Profile & Side Effects

• Hoarseness, sore throat
• Oral thrush (fungal infection in the mouth)
• Headache
• Cough, minor throat irritation
• Nausea

• Fast or irregular heartbeat, tremor
• Muscle cramps or weakness
• Increased risk of pneumonia (COPD patients)
• Suppression of adrenal glands (very high doses, rare)
• Hypersensitivity reactions (rare but serious)

• Do not use as a reliever during acute asthma attacks.
• If you experience severe breathing difficulty shortly after use, seek urgent medical help.
• Report any changes in mood, vision, or prolonged infections to your doctor.

Guidelines for Proper Use

1. Shake MDI inhaler well before each use (dry powder devices do not need shaking).
2. Breathe out fully before inhaling, then inhale medication slowly and deeply.
3. Hold breath for up to 10 seconds if possible, then exhale gently.
4. Rinse mouth and spit out water after each dose to reduce oral thrush risk.
5. Have your inhaler technique checked at least yearly by your pharmacist or nurse.
6. Store inhaler below 30°C. Keep away from direct sunlight and out of reach of children.
7. Check expiry date before use; do not use expired inhalers.
8. Get a new inhaler before you run out and keep a log of doses used.

Alternative Treatment Options (PBS-Listed & Others)

• Budesonide + Eformoterol (Symbicort, Duoresp): Also PBS-listed. Similar efficacy. Can be used as both maintenance and reliever therapy for some patients (SMART regimen). May suit those preferring a single inhaler for all situations.
• Mometasone + Indacaterol (Mometasone-indacaterol DPI): Another combination, but less commonly used.
• Separate Inhalers (Inhaled steroid and long-acting bronchodilator): Less convenient but sometimes clinically preferred.
• Leukotriene Receptor Antagonists (e.g., Montelukast): Tablet option, less effective overall, may be used as adjunct or in mild cases.
• Monotherapy Inhalers (ICS or LABA alone): Only in mild cases or as step-down therapy.

Legal, Registration, and Reimbursement Status in Australia

• Registered with the Therapeutic Goods Administration (TGA).
• Available only on prescription; classified as Schedule 4 (S4) medicine under Australian law.
• Most brands and strengths are covered by the Pharmaceutical Benefits Scheme (PBS) for approved respiratory conditions.
• Patient eligibility for PBS may require evidence of prior therapy and GP or respiratory specialist initiation, per current guidelines.
• Up-to-date product, consumer, and regulatory information is available from the TGA and your local community pharmacist.

Latest Research & Clinical Guidance (2022–2025)

• GINA Guidelines 2023: Combination of inhaled corticosteroid (ICS) and long-acting beta agonist (LABA) is the standard-of-care for persistent asthma uncontrolled by ICS alone, supporting low rates of severe exacerbations and improving patient quality of life (GINA 2023 Report).
• COPD-X Plan (Lung Foundation Australia, 2024): Fluticasone + salmeterol is recommended only for patients at high exacerbation risk due to increased pneumonia risk in COPD; review need periodically.
• Recent meta-analyses (2022–2024): These combinations show robust outcomes for reducing exacerbation frequency without significantly increased serious adverse effects (Wong, 2023, COPD meta-analysis).
• TGA Safety Updates (2023–2024): No new major safety signals; use lowest effective dose and monitor for local steroid side effects (candidiasis, hoarseness).

Availability, Pack Sizes, and Delivery

*Times and prices are indicative for major pharmacy chains, June 2024. Private script cost may vary. Always check with your pharmacy.

FAQ: Common Patient Questions and Answers

1. Can I stop using my Fluticasone + Salmeterol inhaler when I feel better?
   Do not stop suddenly. Always consult your doctor, as regular use is needed to maintain control and prevent sudden flare-ups.
2. How do I know if my inhaler is empty?
   Many devices have dose counters; when it reaches zero, dispose of the inhaler. If uncertain, ask your pharmacist to demonstrate.
3. What if I forget a dose?
   Take it as soon as you remember unless it's nearly time for your next dose. Do not double up. Keep to your regular schedule.
4. Is it safe during pregnancy or breastfeeding?
   Generally considered safe if needed; always discuss with your GP or obstetrician to balance risks and benefits.
5. Can I use my inhaler before playing sport or exercising?
   This is a maintenance (preventer) inhaler, not a reliever. Use as prescribed; if you need extra support, discuss with your doctor about reliever inhaler use.

If you have further questions, speak to your pharmacist, GP, or respiratory specialist. Always follow their advice and the instructions on your prescription label.